English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

U.S. Food And Drug Administration (fda)

Robert Hadley | Jun 28, 2017

Pfizer a step closer to making $17B gamble on biosimilars pay off

Michael McGrady | Jun 22, 2017

FDA chief wants to speed up approvals for digital health tech

Carol Ostrow | Jun 19, 2017

UF study shows selexipag provides potential post-stroke protections

Michael McGrady | Jun 15, 2017

Drug user fee reauthorization may spark innovation

Nicholas Gueguen | Jun 15, 2017

Amgen says cholesterol-lowering drug Repatha may also reduce cardiovascular risks

Michael McGrady | Jun 7, 2017

Federal agencies weigh in on Zika outbreak response

Robert Hadley | Jun 2, 2017

FDA approves higher once-a-day dose of Merck’s Isentress HIV drug 

Robert Hadley | May 31, 2017

FDA greenlights review of Bristol-Myers Squibb’s Opdivo for liver cancer

Trending

+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'

+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’

  • « First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily